Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedUpdated version from v3.0.1 to v3.0.2; removed the Back to Top element. No changes to core content.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%
- Check16 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as updated publications related to IgA nephropathy. Notably, several previously listed locations and related medical topics have been removed.SummaryDifference14%
- Check23 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.2%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.2%
Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.